Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-01 Purchase | 2024-04-03 06:10 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 3,000 | $19.08 | $57,240 | 5,350,777 (Direct) | View |
| 2024-03-22 Purchase | 2024-03-26 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,500 | $19.98 | $49,950 | 5,347,777 (Direct) | View |
| 2024-03-20 Purchase | 2024-03-22 06:02 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,500 | $17.68 | $26,520 | 5,345,277 (Direct) | View |
| 2024-03-05 Purchase(A) | 2024-03-07 09:41 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 3,500 | $12.49 | $43,715 | 5,343,777 (Direct) | View |
| 2024-03-05 Purchase | 2024-03-07 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 30,500 | $12.49 | $380,945 | 5,343,777 (Direct) | View |
| 2024-03-04 Purchase | 2024-03-06 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 4,100 | $13.03 | $53,423 | 5,340,277 (Direct) | View |
| 2024-02-16 Purchase | 2024-02-21 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 10,800 | $11.16 | $120,528 | 5,336,177 (Direct) | View |
| 2024-02-15 Purchase | 2024-02-20 06:04 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 12,700 | $11.07 | $140,589 | 5,325,377 (Direct) | View |
| 2023-11-10 Purchase | 2023-11-14 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 5,000 | $10.17 | $50,838 | 5,312,677 (Direct) | View |
| 2023-11-03 Purchase | 2023-11-07 06:15 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 3,500 | $9.11 | $31,885 | 5,307,677 (Direct) | View |
| 2023-10-27 Purchase | 2023-10-31 06:16 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 500 | $8.57 | $4,285 | 260,348 (Direct) | View |
| 2023-10-26 Purchase | 2023-10-30 06:15 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,500 | $7.97 | $19,925 | 5,304,177 (Direct) | View |
| 2023-10-25 Purchase | 2023-10-27 06:15 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,500 | $7.91 | $19,775 | 5,301,677 (Direct) | View |
| 2023-10-10 Purchase | 2023-10-12 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,000 | $9.07 | $9,070 | 5,299,177 (Direct) | View |
| 2023-10-04 Purchase | 2023-10-05 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,000 | $8.63 | $17,260 | 5,298,177 (Direct) | View |
| 2023-09-26 Purchase | 2023-09-28 06:05 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 600 | $8.71 | $5,226 | 259,848 (Direct) | View |
| 2023-09-19 Purchase | 2023-09-21 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 4,000 | $8.95 | $35,800 | 5,296,177 (Direct) | View |
| 2023-09-11 Purchase | 2023-09-13 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,000 | $9.48 | $9,480 | 5,292,177 (Direct) | View |
| 2023-08-22 Purchase | 2023-08-24 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,000 | $9.97 | $9,970 | 5,291,177 (Direct) | View |
| 2023-08-04 Purchase | 2023-08-08 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,000 | $10.55 | $21,100 | 5,290,177 (Direct) | View |
| 2023-07-21 Purchase | 2023-07-25 06:15 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,000 | $9.2 | $9,200 | 5,288,177 (Direct) | View |
| 2023-07-13 Purchase | 2023-07-17 06:15 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $9.49 | $2,373 | 259,248 (Direct) | View |
| 2023-05-17 Purchase | 2023-05-18 06:01 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,000 | $11.69 | $11,690 | 5,287,177 (Direct) | View |
| 2023-04-28 Purchase | 2023-05-02 06:06 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $11.22 | $2,805 | 258,998 (Direct) | View |
| 2023-04-19 Purchase | 2023-04-21 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 7,000 | $11.1 | $77,700 | 5,286,177 (Direct) | View |
| 2023-04-18 Purchase | 2023-04-20 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,000 | $11.12 | $22,240 | 5,279,177 (Direct) | View |
| 2023-04-11 Purchase | 2023-04-12 06:05 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 1,000 | $11.87 | $11,870 | 258,745 (Direct) | View |
| 2023-04-11 Purchase | 2023-04-12 06:02 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 5,000 | $12.42 | $62,100 | 5,271,177 (Direct) | View |
| 2023-03-15 Purchase | 2023-03-16 06:05 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $12.71 | $3,178 | 257,745 (Direct) | View |
| 2023-03-10 Purchase | 2023-03-13 07:15 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,000 | $12.12 | $12,120 | 2,737,486 (Direct) | View |
| 2023-02-24 Purchase | 2023-02-28 06:03 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $15.39 | $3,849 | 257,495 (Direct) | View |
| 2023-02-17 Purchase | 2023-02-22 06:07 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 600 | $16.53 | $9,918 | 2,736,486 (Direct) | View |
| 2023-02-10 Purchase | 2023-02-14 06:08 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,000 | $18.68 | $18,680 | 2,735,886 (Direct) | View |
| 2023-02-03 Purchase | 2023-02-07 06:10 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $20.84 | $5,210 | 257,245 (Direct) | View |
| 2023-01-27 Purchase | 2023-01-31 06:15 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,000 | $19.35 | $38,700 | 2,734,886 (Direct) | View |
| 2023-01-27 Purchase | 2023-01-30 06:15 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $19.2 | $4,800 | 256,995 (Direct) | View |
| 2023-01-20 Purchase | 2023-01-24 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,500 | $17.37 | $26,055 | 2,732,886 (Direct) | View |
| 2023-01-13 Purchase | 2023-01-17 06:02 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $16.5 | $4,125 | 256,745 (Direct) | View |
| 2023-01-06 Purchase | 2023-01-10 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,500 | $15.18 | $22,770 | 2,731,386 (Direct) | View |
| 2022-12-29 Purchase | 2023-01-03 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 4,000 | $15.19 | $60,760 | 2,729,886 (Direct) | View |